[Non-A, non-B hepatitis in patients with chronic hemodialysis]. 1984

G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor

A prospective study was conducted of the incidence and course of acute viral hepatitis in 69 chronic hemodialysis patients. During a mean observation period of 15.4 months, 5.6 cases/100 patients/year of non-A, non-B hepatitis and 1.1 cases/100 patients/year of hepatitis B virus infection occurred. 19 out of 38 patients with serologic evidence of immunity against hepatitis B virus infection developed the antibody to hepatitis B surface antigen after active immunization. All cases of non-A, non-B hepatitis had an asymptomatic course, but there was a tendency to chronicity. The overall impact of non-A, non-B hepatitis in patients on chronic hemodialysis is discussed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis

Related Publications

G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
January 1992, Nephron,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
January 1987, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
December 1979, La Presse medicale,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
October 2001, Clinical chemistry and laboratory medicine,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
March 1979, La Nouvelle presse medicale,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
January 1983, Developments in biological standardization,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
January 1992, Nephron,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
August 2021, Journal of gastroenterology and hepatology,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
January 2003, Lijecnicki vjesnik,
G Bansky, and P J Grob, and H I Joller-Jemelka, and K Zaruba, and H Iselin, and H J Gloor
April 1982, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale B, Hygiene,
Copied contents to your clipboard!